GSK2190915 Moderate to Severe Asthma Study

NCT00850642 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: GSK2190195 100mg
DRUG: Placebo

Sponsor

GlaxoSmithKline